ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Kesios Therapeutics Limited

Kesios Therapeutics Limited is a dissolved company incorporated on 13 July 2012 with the registered office located in London, City of London. Kesios Therapeutics Limited was registered 13 years ago.
Status
Dissolved
Dissolved on 28 February 2024 (1 year 8 months ago)
Was 11 years old at the time of dissolution
Following liquidation
Company No
08143109
Private limited company
Age
13 years
Incorporated 13 July 2012
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Address
C/O CORK GULLY LLP
6 Snow Hill
London
EC1A 2AY
Address changed on 7 Nov 2022 (3 years ago)
Previous address was 30 Broad Street Great Cambourne Cambridge Cambridgeshire CB23 6HJ
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
11
Controllers (PSC)
1
Director • Investment Manager • British • Lives in UK • Born in Feb 1972
Director • United Kingdom • Lives in British • Born in Mar 1976
Touchstone Innovations Businesses LLP
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Touchstone Innovations Businesses LLP
Maina Bhaman and Dayle Spencer Hogg are mutual people.
Active
Myricx Pharma Limited
Maina Bhaman is a mutual person.
Active
Purespring Therapeutics Limited
Maina Bhaman is a mutual person.
Active
Elevara Medicines Limited
Maina Bhaman is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2013–2022)
Period Ended
31 Jan 2022
For period 31 Jul31 Jan 2022
Traded for 18 months
Cash in Bank
£150.51K
Decreased by £53.76K (-26%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£151.22K
Decreased by £53.48K (-26%)
Total Liabilities
-£549.07K
Increased by £49.18K (+10%)
Net Assets
-£397.85K
Decreased by £102.65K (+35%)
Debt Ratio (%)
363%
Increased by 118.88% (+49%)
Latest Activity
Dissolved After Liquidation
1 Year 8 Months Ago on 28 Feb 2024
Margaret Mary Daniel Resigned
2 Years 1 Month Ago on 25 Sep 2023
Declaration of Solvency
2 Years 12 Months Ago on 15 Nov 2022
Registered Address Changed
3 Years Ago on 7 Nov 2022
Voluntary Liquidator Appointed
3 Years Ago on 4 Nov 2022
Full Accounts Submitted
3 Years Ago on 3 Aug 2022
Accounting Period Extended
3 Years Ago on 28 Jul 2022
Confirmation Submitted
3 Years Ago on 26 Jul 2022
Confirmation Submitted
4 Years Ago on 23 Jul 2021
Full Accounts Submitted
4 Years Ago on 12 May 2021
Get Credit Report
Discover Kesios Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved following liquidation
Submitted on 28 Feb 2024
Return of final meeting in a members' voluntary winding up
Submitted on 28 Nov 2023
Termination of appointment of Margaret Mary Daniel as a secretary on 25 September 2023
Submitted on 5 Oct 2023
Declaration of solvency
Submitted on 15 Nov 2022
Registered office address changed from 30 Broad Street Great Cambourne Cambridge Cambridgeshire CB23 6HJ to 6 Snow Hill London EC1A 2AY on 7 November 2022
Submitted on 7 Nov 2022
Resolutions
Submitted on 4 Nov 2022
Appointment of a voluntary liquidator
Submitted on 4 Nov 2022
Second filing of a statement of capital following an allotment of shares on 22 August 2022
Submitted on 19 Oct 2022
Resolutions
Submitted on 6 Sep 2022
Statement of capital following an allotment of shares on 22 August 2022
Submitted on 6 Sep 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year